Inside the First Autism Impact ETF (ASD) & Algorithmic Risk Management with Wayne Panelo
Why It Matters
ASD creates the first liquid, diversified investment vehicle giving investors targeted exposure to an under-served but fast-growing autism care ecosystem while tying capital allocation to potential social impact. The launches underscore Defiance’s rapid product expansion and reflect broader demand for thematic and algorithmic active ETFs in today’s market.
Summary
Defiance ETFs last week launched the Defiance Autism Impact ETF (ASD), the first ETF expressly targeting companies developing therapies, diagnostics, educational tools and assistive technologies for autism and related neurodevelopmental conditions. The index-based fund tracks the Vetify Autism Impact Index and was driven in part by a personal connection at the firm — the founder’s family experience with autism — shaping a thematic basket across biotech, digital health and education segments. The conversation also highlighted Defiance’s rapid growth—now over $13 billion in AUM—and the firm’s other hits, including the Defiance Quantum ETF (QTUM), which has surged this year. The podcast previewed a separate segment on NextGen’s algorithmic long-short ETF (EMPB), signaling growing investor appetite for both purpose-driven and quant-driven active strategies.
Comments
Want to join the conversation?
Loading comments...